A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
| Autor: | Robert Field, Lucy Edgson, Sarah Westlake |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Foot ulcerations
medicine.medical_specialty Ankylosing spondylitis lcsh:Diseases of the musculoskeletal system business.industry Soft tissue medicine.disease Infliximab Surgery Internal medicine Concomitant Poster Presentation Orthopedic surgery medicine Tumor necrosis factor alpha Orthopedics and Sports Medicine lcsh:RC925-935 business Foot deformity medicine.drug |
| Zdroj: | Journal of Foot and Ankle Research, Vol 3, Iss Suppl 1, p P6 (2010) Journal of Foot and Ankle Research |
| ISSN: | 1757-1146 |
| DOI: | 10.1186/1757-1146-3-s1-p6 |
| Popis: | The BSR Biologics Register demonstrates increased risk of serious soft tissue infections in anti-TNFα managed patients. Mobility levels may increase with successful symptom management. However patients’ feet present with a combination of foot deformity and compromised tissue viability, with associated risk of ulceration and concomitant infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|